0001225208-12-022268.txt : 20121102
0001225208-12-022268.hdr.sgml : 20121102
20121102165742
ACCESSION NUMBER: 0001225208-12-022268
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20121024
FILED AS OF DATE: 20121102
DATE AS OF CHANGE: 20121102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Moed Samuel J
CENTRAL INDEX KEY: 0001561017
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01136
FILM NUMBER: 121177486
MAIL ADDRESS:
STREET 1: BRISTOL-MYERS SQUIBB COMPANY
STREET 2: ROUTE 206 & PROVINCELINE ROAD
CITY: LAWRENCEVILLE
STATE: NJ
ZIP: 08543
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO
CENTRAL INDEX KEY: 0000014272
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 220790350
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
BUSINESS PHONE: 2125464000
MAIL ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
FORMER COMPANY:
FORMER CONFORMED NAME: BRISTOL MYERS CO
DATE OF NAME CHANGE: 19891012
3
1
doc3.xml
X0206
3
2012-10-24
0
0000014272
BRISTOL MYERS SQUIBB CO
BMY
0001561017
Moed Samuel J
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVENUE
NEW YORK
NY
10154
1
SVP, Strat Plan & Analysis
Common Stock, $0.10 par value
9658.4640
D
Common Stock, $0.10 par value
300.0000
I
By Son #1
Common Stock, $0.10 par value
300.0000
I
By Son #2
Market Share Units
2015-03-01
Common Stock, $0.10 par value
3522.0000
D
Market Share Units
2014-03-02
Common Stock, $0.10 par value
2633.0000
D
Market Share Units
2016-03-06
Common Stock, $0.10 par value
4172.0000
D
Option (right to buy)
17.5100
2019-03-02
Common Stock, $0.10 par value
31152.0000
D
Option (right to buy)
22.1400
2018-03-03
Common Stock, $0.10 par value
27938.0000
D
Option (right to buy)
22.7300
2016-03-06
Common Stock, $0.10 par value
16100.0000
D
Option (right to buy)
25.4500
2015-02-28
Common Stock, $0.10 par value
22000.0000
D
Option (right to buy)
27.0100
2017-03-05
Common Stock, $0.10 par value
19650.0000
D
Option (right to buy)
28.1100
2014-03-01
Common Stock, $0.10 par value
22000.0000
D
Performance Shares
2013-03-31
Common Stock, $0.10 par value
7453.8600
D
Performance Shares
2014-03-31
Common Stock, $0.10 par value
3465.2400
D
Restricted Stock Units
2013-03-03
Common Stock, $0.10 par value
1936.0000
D
Restricted Stock Units
2014-05-01
Common Stock, $0.10 par value
10000.0000
D
Shares held in custodial accounts for the benefit of Son #1 under the Uniform Transfer to Minors Act.
The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purposes.
1,174 market share units will vest on each of March 1, 2013, March 1, 2014, and March 1, 2015.
Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the vesting date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.
1,316 market share units will vest on March 2, 2013, and 1,317 market share units will vest on March 2, 2014.
Twenty-five percent of the market share unit award will vest on each of the first, second, third, and fourth anniversaries of the grant date, starting on March 6, 2013.
20,864 shares are currently exercisable. The remaining 10,288 shares will become exercisable on March 3, 2013.
All of the shares are currently exercisable.
Consists of 6,834 performance shares and 619.86 performance shares representing dividend equivalents earned under the 2010-2012 Long Term Performance Award.
Each performance share converts into one share of common stock upon distribution in the first quarter of 2013.
Consists of 3,252 performance shares and 213.24 performance shares representing dividend equivalents earned under the 2011-2013 Long Term Performance Award.
Each performance share converts into one share of common stock upon distribution in the first quarter of 2014.
These restricted stock units will vest on March 3, 2013.
Each restricted stock unit converts into one share of common stock upon vesting.
5,000 restricted stock units will vest on each of May 1, 2013 and May 1, 2014.
Exhibit 24 - Power of Attorney
/s/ Robert J. Wollin, attorney-in-fact for Samuel J. Moed
2012-11-02
EX-24
2
moed_poa.txt
Exhibit 24
POWER OF ATTORNEY
I, Samuel J. Moed, Senior Vice President, Strategic Planning and
Analysis of Bristol-Myers Squibb Company (the "Company"), a corporation duly
organized and existing under the laws of the State of Delaware, in the
United States of America, and having its principal place of business at
345 Park Avenue, New York, New York, do hereby constitute and appoint each of
Sandra Leung, Katherine R. Kelly, and Robert J. Wollin, individually, as my
lawful attorney-in-fact and in my name, place and stead to execute and deliver
any and all documents relating to insider reporting requirements under
Section 16 of the Securities Exchange Act of 1934, with respect to securities
issued by the Company, including, without limitation, the execution and filing
of all Forms 3, 4 and 5, and to take such other action, as such attorney
considers necessary or appropriate, to effectuate such transactions. This Power
of Attorney shall remain in full force and effect until I am no longer required
to file Forms 3, 4, and 5 with respect to securities issued by the Company,
unless earlier revoked.
IN WITNESS WHEREOF, I have executed this Power of Attorney on this
24th day of October, 2012.
/s/ Samuel J. Moed
Samuel J. Moed